A carregar...
Thioaptamers Targeting Dengue Virus Type-2 Envelope Protein Domain III
Thioaptamers targeting the dengue-2 virus (DENV-2) envelope protein domain III (EDIII) were developed. EDIII, which contains epitopes for binding neutralizing antibodies, is the putative host-receptor binding domain and is thus an attractive target for development of vaccines, anti-viral therapeutic...
Na minha lista:
Publicado no: | Biochem Biophys Res Commun |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4272640/ https://ncbi.nlm.nih.gov/pubmed/25261724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2014.09.053 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|